First National Bank of Mount Dora’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.7M Sell
42,339
-382
-0.9% -$82.2K 2.13% 12
2026
Q1
$9.29M Sell
42,721
-2,870
-6% -$637K 2.01% 16
2025
Q4
$10.4M Sell
45,591
-351
-0.8% -$80K 2.28% 13
2025
Q3
$10.6M Sell
45,942
-1,069
-2% -$218K 2.35% 10
2025
Q2
$8.73M Sell
47,011
-551
-1% -$102K 1.97% 18
2025
Q1
$9.97M Sell
47,562
-9,387
-16% -$1.82M 2.43% 12
2024
Q4
$10.1M Buy
56,949
+701
+1% +$129K 2.37% 7
2024
Q3
$11.1M Buy
56,248
+6,420
+13% +$1.2M 2.52% 6
2024
Q2
$8.55M Buy
49,828
+8,488
+21% +$1.41M 2.06% 10
2024
Q1
$7.53M Sell
41,340
-1,576
-4% -$272K 1.83% 16
2023
Q4
$6.65M Sell
42,916
-1,293
-3% -$189K 1.77% 16
2023
Q3
$6.59M Sell
44,209
-1,049
-2% -$154K 1.95% 15
2023
Q2
$6.1M Sell
45,258
-6,784
-13% -$995K 1.73% 17
2023
Q1
$8.29M Buy
52,042
+2,125
+4% +$325K 2.51% 7
2022
Q4
$8.07M Buy
49,917
+210
+0.4% +$32.2K 2.66% 5
2022
Q3
$6.67M Buy
49,707
+3,445
+7% +$494K 2.36% 7
2022
Q2
$7.09M Sell
46,262
-447
-1% -$68.3K 2.44% 8
2022
Q1
$7.57M Buy
46,709
+6,715
+17% +$975K 2.28% 9
2021
Q4
$5.42M Buy
39,994
+1
+0% +$118 1.6% 26
2021
Q3
$4.31M Sell
39,993
-708
-2% -$80.9K 1.42% 30
2021
Q2
$4.58M Sell
40,701
-911
-2% -$103K 1.51% 30
2021
Q1
$4.5M Sell
41,612
-11,918
-22% -$1.27M 1.57% 30
2020
Q4
$5.74M Buy
53,530
+46
+0.1% +$4.42K 2.08% 13
2020
Q3
$4.68M Buy
53,484
+959
+2% +$90.3K 1.94% 19
2020
Q2
$5.16M Sell
52,525
-4,956
-9% -$436K 2.34% 13
2020
Q1
$4.38M Sell
57,481
-2,653
-4% -$226K 2.31% 11
2019
Q4
$5.32M Buy
60,134
+410
+0.7% +$34K 2.24% 13
2019
Q3
$4.52M Buy
59,724
+1,177
+2% +$80.7K 2.07% 17
2019
Q2
$4.26M Buy
58,547
+995
+2% +$78.2K 1.96% 20
2019
Q1
$4.64M Buy
57,552
+10,072
+21% +$824K 2.04% 15
2018
Q4
$4.38M Sell
47,480
-1,112
-2% -$97.8K 2.18% 16
2018
Q3
$4.6M Sell
48,592
-17,122
-26% -$1.62M 1.97% 19
2018
Q2
$6.09M Buy
65,714
+1,665
+3% +$163K 2.73% 8
2018
Q1
$6.06M Buy
64,049
+8,184
+15% +$899K 2.79% 7
2017
Q4
$5.4M Sell
55,865
-4,600
-8% -$434K 2.38% 13
2017
Q3
$5.37M Buy
60,465
+229
+0.4% +$17.4K 2.64% 11
2017
Q2
$4.37M Sell
60,236
-10,590
-15% -$712K 2.27% 18
2017
Q1
$4.62M Buy
70,826
+16,850
+31% +$1.06M 2.48% 8
2016
Q4
$3.38M Buy
53,976
+1,727
+3% +$105K 2% 19
2016
Q3
$3.29M Sell
52,249
-7,041
-12% -$456K 1.85% 20
2016
Q2
$3.67M Buy
59,290
+1,452
+3% +$88.5K 2.1% 10
2016
Q1
$3.3M Buy
57,838
+3,995
+7% +$223K 1.95% 14
2015
Q4
$3.19M Buy
53,843
+345
+0.6% +$19.9K 1.88% 18
2015
Q3
$2.91M Buy
53,498
+3,883
+8% +$253K 1.78% 23
2015
Q2
$3.33M Buy
49,615
+1,613
+3% +$105K 1.86% 18
2015
Q1
$2.81M Buy
48,002
+4,220
+10% +$255K 1.52% 28
2014
Q4
$2.87M Buy
43,782
+9,925
+29% +$626K 1.6% 24
2014
Q3
$1.96M Buy
33,857
+3,750
+12% +$208K 1.15% 35
2014
Q2
$1.7M Sell
30,107
-125
-0.4% -$6.56K 0.99% 43
2014
Q1
$1.55M Buy
30,232
+16,950
+128% +$857K 0.95% 45
2013
Q4
$701K Buy
13,282
+1,450
+12% +$71.3K 0.46% 64
2013
Q3
$529K Sell
11,832
-1,525
-11% -$67.6K 0.39% 68
2013
Q2
$552K Buy
+13,357
New +$584K 0.41% 65

Other funds holding ABBV

First National Bank of Mount Dora's ABBV Position: Q2 2026 in Review

First National Bank of Mount Dora reduced its AbbVie (ABBV) stake by 0.89% in Q2 2026, selling an estimated $82.2K and leaving 42,339 shares worth $10.7M. The position accounts for 2.13% of the portfolio, ranked #12.

First National Bank of Mount Dora first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.1M in Q3 2024. 2,611 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • First National Bank of Mount Dora held 42,339 shares of AbbVie worth $10.7M as of Q2 2026.
  • First National Bank of Mount Dora sold 382 AbbVie shares in Q2 2026, an estimated $82.2K.
  • AbbVie made up 2.13% of First National Bank of Mount Dora's portfolio in Q2 2026, its #12 holding.
  • First National Bank of Mount Dora first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • First National Bank of Mount Dora's AbbVie position peaked at $11.1M in Q3 2024.
  • 2,611 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on First National Bank of Mount Dora's 13F filing for Q2 2026, filed 8 Jul 2026.